4 news items
Rallybio Corporation Announces FNAIT Systematic Literature Review And Meta-Analysis Presented At The Academy Of Managed Care Pharmacy 2024 Annual Meeting
RLYB
17 Apr 24
), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe
FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
RLYB
17 Apr 24
biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
RLYB
10 Apr 24
(NASDAQ:RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
RLYB
1 Apr 24
), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies
- Prev
- 1
- Next